Fate Therapeutics, Inc.Fate Therapeutics, Inc.Fate Therapeutics, Inc.

Fate Therapeutics, Inc.

No trades
See on Supercharts

FATE fundamentals

An in-depth look to Fate Therapeutics, Inc. operating, investing, and financing activities

FATE free cash flow for Q2 24 is -32.36 M USD. For 2023, FATE free cash flow was -138.42 M USD and operating cash flow was -132.26 M USD.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Free cash flowYoY growth